{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T19:38:57Z","timestamp":1771011537970,"version":"3.50.1"},"reference-count":29,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.3892\/ol.2013.1139","type":"journal-article","created":{"date-parts":[[2013,1,18]],"date-time":"2013-01-18T08:17:58Z","timestamp":1358497078000},"page":"1321-1324","source":"Crossref","is-referenced-by-count":7,"title":["Successful treatment with low-dose decitabine in acute myelogenous leukemia in elderly patients over 80 years old: Five case reports"],"prefix":"10.3892","volume":"5","author":[{"given":"JIE","family":"LIN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HONGLI","family":"ZHU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SUXIA","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HUI","family":"FAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XUECHUN","family":"LU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CHENG","family":"CHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BO","family":"GUO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BING","family":"ZHAI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2013,1,18]]},"reference":[{"key":"key20180108092523_b1-ol-05-04-1321","volume-title":"SEER Cancer Statistics Review, 1975\u20132007","author":"Altekruse","year":"2010"},{"key":"key20180108092523_b2-ol-05-04-1321","first-page":"1327","article-title":"Acute lymphoblastic leukemia in the elderly. A twelve-year retrospective, single center study","volume":"85","author":"Pagano","year":"2000","journal-title":"Haematologica"},{"key":"key20180108092523_b3-ol-05-04-1321","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1182\/blood.V89.9.3323","article-title":"Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study","volume":"89","author":"Leith","year":"1997","journal-title":"Blood"},{"key":"key20180108092523_b4-ol-05-04-1321","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1200\/JCO.1999.17.11.3569","article-title":"Management of acute myeloid leukemia in elderly patients","volume":"17","author":"Hiddemann","year":"1999","journal-title":"J Clin Oncol"},{"key":"key20180108092523_b5-ol-05-04-1321","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1365-2141.2001.03043.x","article-title":"Prognostic significance of risk group stratification in elderly patients with acute myeloid leukaemia","volume":"115","author":"Wahlin","year":"2001","journal-title":"Br J Haematol"},{"key":"key20180108092523_b6-ol-05-04-1321","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1200\/JCO.1989.7.11.1637","article-title":"Efficacy of intensive chemotherapy for acute myelogenous leukemia associated with preleukemic syndrome","volume":"7","author":"Gajewski","year":"1989","journal-title":"J Clin Oncol"},{"key":"key20180108092523_b7-ol-05-04-1321","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7326\/0003-4819-103-2-195","article-title":"Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin\u2019s lymphomas: comparison with results obtained in patients treated for Hodgkin\u2019s disease and ovarian carcinoma with other alkylating agents","volume":"103","author":"Pedersen-Bjergaard","year":"1985","journal-title":"Ann Intern Med"},{"key":"key20180108092523_b8-ol-05-04-1321","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/cncr.21723","article-title":"Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome","volume":"106","author":"Kantarjian","year":"2006","journal-title":"Cancer"},{"key":"key20180108092523_b9-ol-05-04-1321","first-page":"139","article-title":"Clinical analysis of 12 acute leukemia patients aged over 80 years","volume":"19","author":"Lin","year":"2011","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"key20180108092523_b10-ol-05-04-1321","first-page":"1490","article-title":"Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia","volume":"7","author":"Bross","year":"2001","journal-title":"Clin Cancer Res"},{"key":"key20180108092523_b11-ol-05-04-1321","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1182\/blood-2003-06-2071","article-title":"Efficacy and safety of imatinib in adult patients with c-kit-positive acute myeloid leukemia","volume":"103","author":"Kindler","year":"2004","journal-title":"Blood"},{"key":"key20180108092523_b12-ol-05-04-1321","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1200\/JCO.2002.04.117","article-title":"Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B","volume":"20","author":"Silverman","year":"2002","journal-title":"J Clin Oncol"},{"key":"key20180108092523_b13-ol-05-04-1321","first-page":"135","article-title":"DNA methylation inhibitors in the treatment of leukemias, myelodysplastic syndromes and hemoglobinopathies: clinical results and possible mechanisms of action","volume":"249","author":"L\u00fcbbert","year":"2000","journal-title":"Curr Top Microbiol Immunol"},{"key":"key20180108092523_b14-ol-05-04-1321","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1532\/IJH97.04094","article-title":"DNA methylation as a therapeutic target in hematologic disorders: recent results in older patients with myelodysplasia and acute myeloid leukemia","volume":"80","author":"R\u00fcter","year":"2004","journal-title":"Int J Hematol"},{"key":"key20180108092523_b15-ol-05-04-1321","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.yexcr.2004.02.001","article-title":"The hierarchical relationship between MAPK signaling and ROS generation in human leukemia cells undergoing apoptosis in response to the proteasome inhibitor Bortezomib","volume":"295","author":"Yu","year":"2004","journal-title":"Exp Cell Res"},{"key":"key20180108092523_b16-ol-05-04-1321","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1182\/blood-2002-10-2998","article-title":"A phase 2 clinical study of SU5416 in patients with refractory acute myeloid leukemia","volume":"102","author":"Fiedler","year":"2003","journal-title":"Blood"},{"key":"key20180108092523_b17-ol-05-04-1321","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrc1169","article-title":"The role of FLT3 in haematopoietic malignancies","volume":"3","author":"Stirewalt","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"key20180108092523_b18-ol-05-04-1321","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1182\/blood-2002-06-1899","article-title":"Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia","volume":"101","author":"Marcucci","year":"2003","journal-title":"Blood"},{"key":"key20180108092523_b19-ol-05-04-1321","first-page":"226","article-title":"5-Aza-2\u2032-deoxycytidine (decitabine) is an effective agent for the treatment of advanced myelodysplastic syndromes (MDS)","volume":"11","author":"Zagonel","year":"1992","journal-title":"Proc Am Soc Clin Oncol"},{"issue":"Suppl 1","key":"key20180108092523_b20-ol-05-04-1321","first-page":"51","article-title":"5-Aza-2\u2032deoxycytidine (decitabine) and 5-azacytidine in the treatment of acute myeloid leukemias and myelodysplastic syndromes: past, present, and future trends","volume":"7","author":"Pinto","year":"1993","journal-title":"Leukemia"},{"key":"key20180108092523_b21-ol-05-04-1321","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.leukres.2007.08.004","article-title":"Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML)","volume":"32","author":"Wijermans","year":"2008","journal-title":"Leuk Res"},{"key":"key20180108092523_b22-ol-05-04-1321","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1200\/JCO.2005.11.981","article-title":"Phase II study of low-dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylate","volume":"23","author":"Issa","year":"2005","journal-title":"J Clin Oncol"},{"key":"key20180108092523_b23-ol-05-04-1321","doi-asserted-by":"crossref","first-page":"6489","DOI":"10.1038\/sj.onc.1206814","article-title":"Epigenetic targets in hematopoietic malignancies","volume":"22","author":"Claus","year":"2003","journal-title":"Oncogene"},{"key":"key20180108092523_b24-ol-05-04-1321","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1200\/JCO.2009.23.9178","article-title":"Multicenter, phase II study of decitabine for the first-line treatment of older patients with acute myeloid leukemia","volume":"28","author":"Cashen","year":"2010","journal-title":"J Clin Oncol"},{"key":"key20180108092523_b25-ol-05-04-1321","doi-asserted-by":"crossref","first-page":"7473","DOI":"10.1073\/pnas.1002650107","article-title":"Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine","volume":"107","author":"Blum","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108092523_b26-ol-05-04-1321","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3324\/haematol.2011.048231","article-title":"A multicenter phase II trial of decitabine as first-line treatment for older AML patients with acute myeloid leukemia judged unfit for induction chemotherapy","volume":"97","author":"L\u00fcbbert","year":"2012","journal-title":"Haematologica"},{"key":"key20180108092523_b27-ol-05-04-1321","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1182\/blood-2006-03-009142","article-title":"Phase 1\/2 study of the combination of 5-aza-2\u2032-deoxycytidine with valproic acid in patients with leukemia","volume":"108","author":"Garcia-Manero","year":"2006","journal-title":"Blood"},{"key":"key20180108092523_b28-ol-05-04-1321","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1365-2141.1996.4771012.x","article-title":"Treatment of newly diagnosed acute myelogenous leukaemia in patients aged 80 years and above","volume":"93","author":"DeLima","year":"1996","journal-title":"Br J Haematol"},{"key":"key20180108092523_b29-ol-05-04-1321","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/ajh.10235","article-title":"Conservative treatment for patients over 80 years with acute myelogenous leukemia","volume":"71","author":"Latagliata","year":"2002","journal-title":"Am J Hematol"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2013.1139\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T17:44:32Z","timestamp":1595267072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2013.1139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,18]]},"references-count":29,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,1,18]]},"published-print":{"date-parts":[[2013,4]]}},"alternative-id":["10.3892\/ol.2013.1139"],"URL":"https:\/\/doi.org\/10.3892\/ol.2013.1139","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,18]]}}}